NHS Health Technology Assessment Programme: Clinical Trials

7 trials sponsored by NHS Health Technology Assessment Programme, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 terminated. 4 Phase 4, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Terminated 1, Unknown 1
Not applicable3Completed 2, Unknown 1

Follow NHS Health Technology Assessment Programme: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety
Sertraline, Cognitive Behavioural Therapy - Generalised Anxiety Disorder
Phase 4TerminatedUniversity College, London52014-08-012016-07-11
Antibiotic Prophylaxis for Clean Intermittent Catheterisation
Nitrofurantoin or Trimethoprim or Cefalexin, No prophylaxis - Urinary Tract Infections, Recurrent
Phase 4CompletedNewcastle-upon-Tyne Hospitals NHS Trust4042013-09-012018-03-30
Sheffield Physical Activity Booster Trial
Mini Booster, Full Booster - Public Health
Not applicableCompletedRichard Hudson2822009-11-012014-12-02
Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
Protease Inhibitor, Standard-of-care Antiretroviral therapy - HIV Infection, Acquired Immunodeficiency Syndrome
Phase 4UnknownMedical Research Council5872008-11-012012-10-10
Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients
CEA, CAS - Carotid Stenosis
Not applicableUnknownUniversity of Oxford36382008-01-012024-12-09
Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial
Folic Acid, Placebo - Depression
Phase 4CompletedBangor University7302007-07-012011-10-12
Assessing the Effectiveness of Communication Therapy in the North West (The ACT NoW Pilot Study)
Speech and Language therapy for dysarthria and/or aphasia - Speech or Language Impairment Following Stroke
Not applicableCompletedNHS Health Technology Assessment Programme602005-02-012005-09-12

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  Behavior (1)  ·  Carotid Stenosis (1)  ·  Depression (1)  ·  Generalized Anxiety Disorder (1)  ·  HIV Infections (1)  ·  Health Behavior (1)  ·  Immune System Diseases (1)  ·  Motor Activity (1)  ·  RNA Virus Infections (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Speech (1)  ·  Urinary Tract Infections (1)  ·  Virus Diseases (1)

Interventions

Cephalexin (1)  ·  Cognitive Behavioral Therapy (1)  ·  Folic Acid (1)  ·  Language Therapy (1)  ·  Nitrofurantoin (1)  ·  Protease Inhibitors (1)  ·  Sertraline (1)  ·  Trimethoprim (1)

Countries

United Kingdom (6)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)

Top investigators

Alison Halliday (1)  ·  Audrey Bowen, PhD (1)  ·  Ian T Russell, PhD, HonFRCGP, FRCP Edin, FFPH (1)  ·  Keith Lloyd, MBBS, MSc, MRC Psych, MSc, MD (1)  ·  Liddy Goyder, MD FFPH (1)  ·  Marta Buszewicz (1)  ·  Nick Paton, MD (1)  ·  Robert Pickard, MD (1)

Results publications

PMID 20047672, PMID 23646111, PMID 24571932, PMID 26908117